During the 57th Annual FDA Honor Awards Ceremony on Thursday, June 29, 2017, two members of the NCAC family were honored for their work at the US Food and Drug Administration. The FDA Honor Awards are designed to highlight the extraordinary expertise demonstrated by employees of the FDA and these employees’ commitment to ensure and improve public health.
Peter L Goering, Ph.D. received the Scientific Achievement - Lifetime Achievement Award for sustained, outstanding contributions and exemplary leadership in toxicology to improve the safety assessment of FDA regulated products.
Peter Petrochenko, Ph.D. received the Scientific Achievement Award for Outstanding InterCenter Scientific Collaboration for his work with the Complex Generic Drug Product Bioequivalence Guidance Development Team. He was recognized for the outstanding Intercenter group effort in developing bioequivalence guidance for complex generic drug products containing nanomaterials.